[Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosis]

Alejandra B Camargo1, Walter Manucha2

  • 1IBAM, UNCuyo, CONICET, Facultad de Ciencias Agrarias, Chacras de Coria, Mendoza, Argentina; Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Cuyo, Mendoza, Argentina.

Insights

Atherosclerosis involves mitochondrial dysfunction, oxidative stress, and inflammation. Nitric oxide (NO) bioavailability is linked to these processes and may influence heat shock protein expression, suggesting functional foods for prevention.

Area of Science:

  • Cardiovascular Research
  • Pathophysiology
  • Molecular Biology

Background:

  • Atherosclerosis is a global health issue with complex mechanisms.
  • Mitochondrial dysfunction, oxidative stress, and inflammation are hallmarks of the disease.
  • Nitric oxide (NO) plays a critical role in these pathological processes.

Purpose of the Study:

  • To explore the relationship between nitric oxide bioavailability and atherosclerosis.
  • To investigate the role of NO in oxidative stress, inflammation, and mitochondrial dysfunction.
  • To examine the connection between NO alterations and heat shock protein expression.

Main Methods:

  • Review of existing literature on atherosclerosis mechanisms.
  • Analysis of the role of nitric oxide in cellular dysfunction.
  • Investigation of functional foods as a preventive strategy.

Main Results:

  • Patients with atherosclerosis exhibit mitochondrial dysfunction, oxidative stress, and inflammation.
  • Nitric oxide is closely implicated in the inflammatory, oxidative, and mitochondrial processes of atherosclerosis.
  • Altered nitric oxide bioavailability may induce heat shock protein expression.

Conclusions:

  • Understanding atherosclerosis mechanisms is key to developing new interventions.
  • Functional foods show promise for preventing vascular aging and atherosclerosis.
  • Targeting nitric oxide pathways could offer therapeutic benefits.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
904
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K